MeSH tree: C08.381.483.652
A lung affected by deadly forms of COVID-19 not only loses essential cells for breathing but also undergoes profound changes in its internal organization and the way its cells communicate with each other. A study involving ...
Oct 16, 2026
0
13
As we grow older, our bodies accumulate "zombie cells"—living cells that have stopped dividing or functioning normally but linger in our tissues, contributing to chronic inflammation and age-related diseases. A new study ...
Oct 5, 2026
0
33
In 2025, Insilico Medicine developed an experimental drug called rentosertib as a treatment for idiopathic pulmonary fibrosis, a severe age-related lung disease. The drug works by inhibiting the protein TNIK, which is involved ...
A bacterial protein fragment called corisin drives pulmonary fibrosis by infiltrating and disrupting cells' quality-control systems, researchers at the University of Illinois Urbana-Champaign and Mie University in Japan found ...
Sep 1, 2026
0
4
Millions of people worldwide are affected by diseases that cause scarring of the lungs, often leading to breathing difficulties and reduced quality of life. Progressive scarring of the lungs can severely impair breathing ...
Aug 28, 2026
0
5
In November 2020, a Belgian racing pigeon called New Kim sold at auction for £1.44 million. The record price offered a striking insight into the money, competition and international interest surrounding pigeon fancying.
Aug 3, 2026
0
14
Pulmonary fibrosis is a deadly disease in which scar tissue grows in the lungs, making breathing more difficult. Approximately 2,170 Australians are diagnosed annually with idiopathic pulmonary fibrosis (IPF), a form of the ...
Jul 16, 2026
0
16
GLP-1 agonists have become popular treatments for weight loss and type 2 diabetes, and newer studies suggest other health benefits as well. Findings from experiments on mice, published in the Journal of Virology, suggest ...
Jul 9, 2026
0
3
Researchers have validated a genetic scoring tool that may help physicians diagnose idiopathic pulmonary fibrosis and identify which patients are at greatest risk for severe outcomes, including death or the need for a lung ...
Jul 7, 2026
0
7
A new Mayo Clinic study shows that integrating telomere length evaluation and genetic testing into pulmonary care can significantly change how physicians diagnose and treat pulmonary fibrosis—in some cases even redirecting ...
Jul 2, 2026
0
3
